NASDAQ:BNGO

Bionano Genomics, Inc Earning Date

USA |NASDAQ |USD

BNGO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.06 $-0.07 $-0.08
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $4.23M $3.86M $2.20M

Bionano Genomics, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

BNGO Earnings Date & History Chart

BNGO Earnings & Revenue Forecast

BNGO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.06 $-0.07 $-0.05
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.22 $-0.23 $-0.21
Dec 2022 3 $-0.25 $-0.31 $-0.19

BNGO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.06 $-0.06 $-0.05
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.22 $-0.22 $-0.18
Dec 2022 1 / 0 $-0.25 $-0.22 $-0.21

BNGO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $5.34M $4.60M $6.25M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $16.58M $15.50M $17.91M
Dec 2022 4 $29.81M $25.20M $35.59M

BNGO Earnings Date & Revenue History

BNGO Earnings History

|
Show More
Show More

BNGO Revenue History

|
Show More
Show More

Bionano Genomics, Inc Next Earnings Date & Report

BNGO Next Earnings Date & Report Preview: Sep 2021 (FQ)

BNGO's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Bionano Genomics, Inc's next quarterly earnings is $-0.06, with a low EPS estimation of $-0.06, and a high estimation of $-0.05.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.06, the last 2 month trend is $-0.06, and the 3 month trend is $-0.05.

Based on 4 analysts, the average revenue estimation is $4.23M, with a low revenue estimation of $3.90M, and a high estimation of $4.64M.

Bionano Genomics, Inc Previous Earnings Dates & Reports

BNGO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bionano Genomics, Inc's previous earnings date was Aug 4, 2021 for its fiscal quarter ended Jun 30, 2021.

BNGO's earnings per share (EPS) was $-0.07, missing the consensus analysts forecast of $-0.05 by -55.56%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 75.00%, and higher than the same period a year before (Jun 2020) by -22.22%.

Revenues were $3.86M, better than the forecast of $3.86M by 0.00%, up by 21.72% from the previous quarter , and up by 226.23% from the same period last year.

The company reported a net income of $-18.79M.

Free cash flow for the quarter was $-12.47M , compared to $-13.93M last quarter and $-7.22M a year before.

BNGO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bionano Genomics, Inc's previous annual earnings date was Mar 23, 2021 for its fiscal year ended Dec 31, 2020.

BNGO's earnings per share (EPS) was $-0.52, missing the consensus analysts forecast of $-0.40 by 30.00% , and higher than the previous year's EPS (Dec 2019) by -78.06%.

Revenues were $8.50M, better than the forecast of $8.01M by 6.15%, and down by -16.06% from previous year's revenue.

The company reported a net income of $-41.11M.

Bionano Genomics, Inc reported a free cash flow of $-38.31M for its fiscal year, compared to $-29.59M a year ago.

The company ended the fiscal year with $36.41M in total debt, an increase of 81.28% compared to the previous year.